Regarding "Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind randomized study": Optimizing initial interventions.
Farber
Guy A
GA
Goldberg
Joseph F
JF
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage*; D000928:Antidepressive Agents / Q000008:administration & dosage*; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors